The downregulation of HIF1A and COPS5 has been shown to inhibit the proliferation and malignant behaviors of cancer cells, suggesting that inhibitors targeting the two proteins may have potential as anticancer therapeutics43,44,47,48. This evidence concerns the gene HIF1A and cancer.